COVID-19 Impact on Global Opioid Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 90 pages | ID: C0D908D21018EN
QYResearch

Abstracts

This report focuses on the global Opioid Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opioid Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Acura Pharmaceuticals
• Cipher Pharmaceutical Inc.
• Daiichi Sankyo
• Johnson?Johnson
• Lupin Limited
• Pfizer
• Sun Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.

Market segment by Type, the product can be split into

• Buprenorphine
• Fentanyl
• Hydrocodone
• Morphine
• Oxycodone
• Tramadol
• Others

Market segment by Application, split into

• Anesthesia
• Pain relief
• Cough suppression
• Diarrhea suppression
• Deaddiction
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Opioid Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Opioid Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Opioid Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Opioid Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Buprenorphine
  1.4.3 Fentanyl
  1.4.4 Hydrocodone
  1.4.5 Morphine
  1.4.6 Oxycodone
  1.4.7 Tramadol
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Opioid Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Anesthesia
  1.5.3 Pain relief
  1.5.4 Cough suppression
  1.5.5 Diarrhea suppression
  1.5.6 Deaddiction
  1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Opioid Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Opioid Drugs Industry
    1.6.1.1 Opioid Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Opioid Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Opioid Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Opioid Drugs Market Perspective (2015-2026)
2.2 Opioid Drugs Growth Trends by Regions
  2.2.1 Opioid Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Opioid Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Opioid Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Opioid Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Opioid Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Opioid Drugs Players by Market Size
  3.1.1 Global Top Opioid Drugs Players by Revenue (2015-2020)
  3.1.2 Global Opioid Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opioid Drugs Market Concentration Ratio
  3.2.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2019
3.3 Opioid Drugs Key Players Head office and Area Served
3.4 Key Players Opioid Drugs Product Solution and Service
3.5 Date of Enter into Opioid Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Opioid Drugs Historic Market Size by Type (2015-2020)
4.2 Global Opioid Drugs Forecasted Market Size by Type (2021-2026)

5 OPIOID DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Opioid Drugs Market Size by Application (2015-2020)
5.2 Global Opioid Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Opioid Drugs Market Size (2015-2020)
6.2 Opioid Drugs Key Players in North America (2019-2020)
6.3 North America Opioid Drugs Market Size by Type (2015-2020)
6.4 North America Opioid Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Opioid Drugs Market Size (2015-2020)
7.2 Opioid Drugs Key Players in Europe (2019-2020)
7.3 Europe Opioid Drugs Market Size by Type (2015-2020)
7.4 Europe Opioid Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Opioid Drugs Market Size (2015-2020)
8.2 Opioid Drugs Key Players in China (2019-2020)
8.3 China Opioid Drugs Market Size by Type (2015-2020)
8.4 China Opioid Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Opioid Drugs Market Size (2015-2020)
9.2 Opioid Drugs Key Players in Japan (2019-2020)
9.3 Japan Opioid Drugs Market Size by Type (2015-2020)
9.4 Japan Opioid Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Opioid Drugs Market Size (2015-2020)
10.2 Opioid Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opioid Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Opioid Drugs Market Size (2015-2020)
11.2 Opioid Drugs Key Players in India (2019-2020)
11.3 India Opioid Drugs Market Size by Type (2015-2020)
11.4 India Opioid Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Opioid Drugs Market Size (2015-2020)
12.2 Opioid Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Opioid Drugs Market Size by Type (2015-2020)
12.4 Central & South America Opioid Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Acura Pharmaceuticals
  13.1.1 Acura Pharmaceuticals Company Details
  13.1.2 Acura Pharmaceuticals Business Overview and Its Total Revenue
  13.1.3 Acura Pharmaceuticals Opioid Drugs Introduction
  13.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020))
  13.1.5 Acura Pharmaceuticals Recent Development
13.2 Cipher Pharmaceutical Inc.
  13.2.1 Cipher Pharmaceutical Inc. Company Details
  13.2.2 Cipher Pharmaceutical Inc. Business Overview and Its Total Revenue
  13.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction
  13.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2015-2020)
  13.2.5 Cipher Pharmaceutical Inc. Recent Development
13.3 Daiichi Sankyo
  13.3.1 Daiichi Sankyo Company Details
  13.3.2 Daiichi Sankyo Business Overview and Its Total Revenue
  13.3.3 Daiichi Sankyo Opioid Drugs Introduction
  13.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2015-2020)
  13.3.5 Daiichi Sankyo Recent Development
13.4 Johnson?Johnson
  13.4.1 Johnson?Johnson Company Details
  13.4.2 Johnson?Johnson Business Overview and Its Total Revenue
  13.4.3 Johnson?Johnson Opioid Drugs Introduction
  13.4.4 Johnson?Johnson Revenue in Opioid Drugs Business (2015-2020)
  13.4.5 Johnson?Johnson Recent Development
13.5 Lupin Limited
  13.5.1 Lupin Limited Company Details
  13.5.2 Lupin Limited Business Overview and Its Total Revenue
  13.5.3 Lupin Limited Opioid Drugs Introduction
  13.5.4 Lupin Limited Revenue in Opioid Drugs Business (2015-2020)
  13.5.5 Lupin Limited Recent Development
13.6 Pfizer
  13.6.1 Pfizer Company Details
  13.6.2 Pfizer Business Overview and Its Total Revenue
  13.6.3 Pfizer Opioid Drugs Introduction
  13.6.4 Pfizer Revenue in Opioid Drugs Business (2015-2020)
  13.6.5 Pfizer Recent Development
13.7 Sun Pharmaceuticals
  13.7.1 Sun Pharmaceuticals Company Details
  13.7.2 Sun Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Sun Pharmaceuticals Opioid Drugs Introduction
  13.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020)
  13.7.5 Sun Pharmaceuticals Recent Development
13.8 Teva Pharmaceutical Industries Ltd.
  13.8.1 Teva Pharmaceutical Industries Ltd. Company Details
  13.8.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  13.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction
  13.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2015-2020)
  13.8.5 Teva Pharmaceutical Industries Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Opioid Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Opioid Drugs Revenue
Table 3. Ranking of Global Top Opioid Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Opioid Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Buprenorphine
Table 6. Key Players of Fentanyl
Table 7. Key Players of Hydrocodone
Table 8. Key Players of Morphine
Table 9. Key Players of Oxycodone
Table 10. Key Players of Tramadol
Table 11. Key Players of Others
Table 12. COVID-19 Impact Global Market: (Four Opioid Drugs Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Opioid Drugs Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Opioid Drugs Players to Combat Covid-19 Impact
Table 17. Global Opioid Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Opioid Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Opioid Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Opioid Drugs Market Share by Regions (2015-2020)
Table 21. Global Opioid Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Opioid Drugs Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Opioid Drugs Market Growth Strategy
Table 27. Main Points Interviewed from Key Opioid Drugs Players
Table 28. Global Opioid Drugs Revenue by Players (2015-2020) (Million US$)
Table 29. Global Opioid Drugs Market Share by Players (2015-2020)
Table 30. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Drugs as of 2019)
Table 31. Global Opioid Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Opioid Drugs Product Solution and Service
Table 34. Date of Enter into Opioid Drugs Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. Global Opioid Drugs Market Size Share by Type (2015-2020)
Table 38. Global Opioid Drugs Revenue Market Share by Type (2021-2026)
Table 39. Global Opioid Drugs Market Size Share by Application (2015-2020)
Table 40. Global Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 41. Global Opioid Drugs Market Size Share by Application (2021-2026)
Table 42. North America Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Opioid Drugs Market Share (2019-2020)
Table 44. North America Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 45. North America Opioid Drugs Market Share by Type (2015-2020)
Table 46. North America Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 47. North America Opioid Drugs Market Share by Application (2015-2020)
Table 48. Europe Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Opioid Drugs Market Share (2019-2020)
Table 50. Europe Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Opioid Drugs Market Share by Type (2015-2020)
Table 52. Europe Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Opioid Drugs Market Share by Application (2015-2020)
Table 54. China Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
Table 55. China Key Players Opioid Drugs Market Share (2019-2020)
Table 56. China Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 57. China Opioid Drugs Market Share by Type (2015-2020)
Table 58. China Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 59. China Opioid Drugs Market Share by Application (2015-2020)
Table 60. Japan Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Opioid Drugs Market Share (2019-2020)
Table 62. Japan Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Opioid Drugs Market Share by Type (2015-2020)
Table 64. Japan Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Opioid Drugs Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Opioid Drugs Market Share (2019-2020)
Table 68. Southeast Asia Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Opioid Drugs Market Share by Type (2015-2020)
Table 70. Southeast Asia Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Opioid Drugs Market Share by Application (2015-2020)
Table 72. India Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
Table 73. India Key Players Opioid Drugs Market Share (2019-2020)
Table 74. India Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 75. India Opioid Drugs Market Share by Type (2015-2020)
Table 76. India Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 77. India Opioid Drugs Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Opioid Drugs Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Opioid Drugs Market Share (2019-2020)
Table 80. Central & South America Opioid Drugs Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Opioid Drugs Market Share by Type (2015-2020)
Table 82. Central & South America Opioid Drugs Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Opioid Drugs Market Share by Application (2015-2020)
Table 84. Acura Pharmaceuticals Company Details
Table 85. Acura Pharmaceuticals Business Overview
Table 86. Acura Pharmaceuticals Product
Table 87. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 88. Acura Pharmaceuticals Recent Development
Table 89. Cipher Pharmaceutical Inc. Company Details
Table 90. Cipher Pharmaceutical Inc. Business Overview
Table 91. Cipher Pharmaceutical Inc. Product
Table 92. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 93. Cipher Pharmaceutical Inc. Recent Development
Table 94. Daiichi Sankyo Company Details
Table 95. Daiichi Sankyo Business Overview
Table 96. Daiichi Sankyo Product
Table 97. Daiichi Sankyo Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 98. Daiichi Sankyo Recent Development
Table 99. Johnson?Johnson Company Details
Table 100. Johnson?Johnson Business Overview
Table 101. Johnson?Johnson Product
Table 102. Johnson?Johnson Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 103. Johnson?Johnson Recent Development
Table 104. Lupin Limited Company Details
Table 105. Lupin Limited Business Overview
Table 106. Lupin Limited Product
Table 107. Lupin Limited Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 108. Lupin Limited Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Product
Table 112. Pfizer Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 113. Pfizer Recent Development
Table 114. Sun Pharmaceuticals Company Details
Table 115. Sun Pharmaceuticals Business Overview
Table 116. Sun Pharmaceuticals Product
Table 117. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 118. Sun Pharmaceuticals Recent Development
Table 119. Teva Pharmaceutical Industries Ltd. Business Overview
Table 120. Teva Pharmaceutical Industries Ltd. Product
Table 121. Teva Pharmaceutical Industries Ltd. Company Details
Table 122. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2015-2020) (Million US$)
Table 123. Teva Pharmaceutical Industries Ltd. Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Opioid Drugs Market Share by Type: 2020 VS 2026
Figure 2. Buprenorphine Features
Figure 3. Fentanyl Features
Figure 4. Hydrocodone Features
Figure 5. Morphine Features
Figure 6. Oxycodone Features
Figure 7. Tramadol Features
Figure 8. Others Features
Figure 9. Global Opioid Drugs Market Share by Application: 2020 VS 2026
Figure 10. Anesthesia Case Studies
Figure 11. Pain relief Case Studies
Figure 12. Cough suppression Case Studies
Figure 13. Diarrhea suppression Case Studies
Figure 14. Deaddiction Case Studies
Figure 15. Others Case Studies
Figure 16. Opioid Drugs Report Years Considered
Figure 17. Global Opioid Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Opioid Drugs Market Share by Regions: 2020 VS 2026
Figure 19. Global Opioid Drugs Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Opioid Drugs Market Share by Players in 2019
Figure 22. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Drugs as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Opioid Drugs Revenue in 2019
Figure 24. North America Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Opioid Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Acura Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 33. Cipher Pharmaceutical Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 35. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 37. Johnson?Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Johnson?Johnson Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 39. Lupin Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 41. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Pfizer Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 43. Sun Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 45. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed